Skip to main content

and
  1. Article

    Open Access

    Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study

    Tamoxifen and aromatase inhibitors are associated with side effects which can significantly impact quality of life (QoL). We assessed QoL in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial and com...

    J. G. H. van Nes, D. B. Y. Fontein, E. T. M. Hille in Breast Cancer Research and Treatment (2012)

  2. Article

    Open Access

    Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients

    In a Japanese study, cyclin-dependent kinase (CDK) based risk determined by CDK 1 and 2 activities was associated with risk of distance recurrence in early breast cancer patients. The aim of our study was to v...

    J G H van Nes, V T H B M Smit, H Putter, P J Kuppen, S J Kim in British Journal of Cancer (2009)